Nicole Shen
Overview
Explore the profile of Nicole Shen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahri M, Shen N, Berrizbeitia F, Rodan R, Daer A, Faigan M, et al.
Acta Biomater
. 2020 Nov;
119:284-302.
PMID: 33181361
Clinical performance of osseointegrated implants could be compromised by the medications taken by patients. The effect of a specific medication on osseointegration can be easily investigated using traditional systematic reviews....
2.
Jesudian A, Barraza L, Steel P, Shen N, Schneider Y, Bodnar D, et al.
Frontline Gastroenterol
. 2019 Dec;
11(1):22-27.
PMID: 31885836
Objective: Early paracentesis (EP) for rapid diagnosis of spontaneous bacterial peritonitis is considered best practice in the care of admitted patients with cirrhosis and ascites, but inpatient paracentesis is frequently...
3.
Rosenblatt R, Shen N, Tafesh Z, Cohen-Mekelburg S, Crawford C, Kumar S, et al.
Liver Transpl
. 2019 Dec;
26(2):187-195.
PMID: 31785079
Acute-on-chronic liver failure (ACLF) carries high short-term mortality. The North American Consortium for the Study of End-Stage Liver Disease (NACSELD)-ACLF score, positive if ≥2 organ failures are present, is a...
4.
Rosenblatt R, Tafesh Z, Shen N, Cohen-Mekelburg S, Kumar S, Lucero C, et al.
Am J Gastroenterol
. 2019 Nov;
114(12):1863-1869.
PMID: 31688022
Introduction: Symptomatic ascites is the most common indication for hospitalization in patients with cirrhosis. Although guidelines recommend paracentesis for all inpatients with ascites, the timing of paracentesis is likely to...
5.
Cohen-Mekelburg S, Rosenblatt R, Wallace B, Shen N, Fortune B, Waljee A, et al.
Am J Manag Care
. 2019 Oct;
25(10):474-481.
PMID: 31622063
Objectives: Hospital care accounts for up to one-third of the cost of inflammatory bowel disease (IBD) management. A select group of patients with IBD is responsible for a large proportion...
6.
Hirsova P, Malhi H, Russo N, Shah P, Trivedi H, Lau D, et al.
Hepatology
. 2019 Aug;
70(2):455-458.
PMID: 31376309
No abstract available.
7.
Rosenblatt R, Cohen-Mekelburg S, Shen N, Tafesh Z, Lucero C, Kumar S, et al.
Am J Gastroenterol
. 2019 Jun;
114(9):1488-1495.
PMID: 31180921
Introduction: Although the Hospital Readmissions Reduction Program (HRRP) has decreased readmissions in targeted conditions, outcomes in high-risk subgroups are unknown. This study analyzed the impact of cirrhosis as a comorbidity...
8.
Nair K, Vora R, Mousa O, Malhi H, Schwartz R, Pisa J, et al.
Hepatology
. 2019 Mar;
69(4):1365-1368.
PMID: 30920689
No abstract available.
9.
Rosenblatt R, Mehta A, Cohen-Mekelburg S, Shen N, Snell D, Lucero C, et al.
Liver Int
. 2019 Feb;
39(7):1263-1270.
PMID: 30790420
Background & Aims: Cirrhotics are at increased risk of Clostridioides difficile infection (CDI) and its associated high morbidity and mortality. However, the impact of CDI in cirrhotics over time remains...
10.
Cohen-Mekelburg S, Rosenblatt R, Gold S, Shen N, Fortune B, Waljee A, et al.
Am J Gastroenterol
. 2018 Nov;
114(2):276-290.
PMID: 30420634
Objectives: Inflammatory bowel disease (IBD) is a complex chronic disease that often requires a multispeciality approach; thus, IBD patients are prone to care fragmentation. We aim to determine the prevalence...